327 related articles for article (PubMed ID: 17087662)
1. Effects of glucagon-like peptide-1-(7-36)-amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK rats.
Svensson AM; Ostenson CG; Efendic S; Jansson L
Clin Sci (Lond); 2007 Jun; 112(6):345-51. PubMed ID: 17087662
[TBL] [Abstract][Full Text] [Related]
2. Lack of compensatory increase in islet blood flow and islet mass in GK rats following 60% partial pancreatectomy.
Svensson AM; Ostenson CG; Bodin B; Jansson L
J Endocrinol; 2005 Feb; 184(2):319-27. PubMed ID: 15684340
[TBL] [Abstract][Full Text] [Related]
3. Reversal of high pancreatic islet and white adipose tissue blood flow in type 2 diabetic GK rats by administration of the beta3-adrenoceptor inhibitor SR-59230A.
Pettersson US; Henriksnäs J; Jansson L
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E490-4. PubMed ID: 19491297
[TBL] [Abstract][Full Text] [Related]
4. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
[TBL] [Abstract][Full Text] [Related]
5. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 1 receptor antagonists prevent glucose-induced increases in islet blood flow in rats.
Iwase M; Uchizono Y; Nohara S; Sasaki N; Sonoki K; Iida M
Scand J Clin Lab Invest; 2009; 69(1):145-50. PubMed ID: 18937099
[TBL] [Abstract][Full Text] [Related]
7. Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats.
Wu L; Olverling A; Fransson L; Ortsäter H; Kappe C; Gao X; Sjöholm A
Regul Pept; 2012 Aug; 177(1-3):92-6. PubMed ID: 22587909
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet blood flow during euglycaemic, hyperinsulinaemic clamp in anaesthetized rats.
Jansson L; Andersson A; Bodin B; Källskog O
Acta Physiol (Oxf); 2007 Apr; 189(4):319-24. PubMed ID: 17367401
[TBL] [Abstract][Full Text] [Related]
9. Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1.
Salehi A; Ekelund M; Lundquist I
Horm Metab Res; 2003 Jan; 35(1):48-54. PubMed ID: 12669271
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide synthase by NG-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats.
Svensson AM; Ostenson CG; Sandler S; Efendic S; Jansson L
Endocrinology; 1994 Sep; 135(3):849-53. PubMed ID: 7520863
[TBL] [Abstract][Full Text] [Related]
11. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
12. Two-week treatment with the β₃-adrenoceptor antagonist SR59230A normalizes the increased pancreatic islet blood flow in type 2 diabetic GK rats.
Pettersson US; Sandberg M; Jansson L
Diabetes Obes Metab; 2012 Oct; 14(10):960-2. PubMed ID: 22564532
[TBL] [Abstract][Full Text] [Related]
13. Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats.
Olverling A; Huang Z; Nyström T; Sjöholm Å
Clin Sci (Lond); 2013 Nov; 125(9):433-8. PubMed ID: 23713675
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of a 50% partial pancreatectomy on total pancreatic and islet blood flow in rats.
Johansson M; Carlsson PO; Bodin B; Andersson A; Källskog O; Jansson L
Pancreas; 2005 Jan; 30(1):71-5. PubMed ID: 15632702
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 C-terminal structures affect its blood glucose lowering-function.
Li Y; Shi C; Lv Q; Zhang H; Li B; Bian G; Huang Q; Zhang W; Xue X; Ren X; Gao H; Sun C; Wang J; Zhang M
J Pept Sci; 2008 Jul; 14(7):777-85. PubMed ID: 18200618
[TBL] [Abstract][Full Text] [Related]
16. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.
Cani PD; Daubioul CA; Reusens B; Remacle C; Catillon G; Delzenne NM
J Endocrinol; 2005 Jun; 185(3):457-65. PubMed ID: 15930172
[TBL] [Abstract][Full Text] [Related]
17. Relationships between the islets blood flow, nitric oxide, insulin, and cytosolic calcium in rat pancreatic islets: effects of DPP-IV inhibitor vildagliptin.
Akarte AS; Srinivasan BP; Gandhi S
Eur J Pharm Sci; 2012 Apr; 45(5):546-51. PubMed ID: 22155545
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycaemia induces decreased islet blood perfusion mediated by the central nervous system in normal and Type 2 diabetic GK rats.
Carlsson PO; Berne C; Ostenson CG; Andersson A; Jansson L
Diabetologia; 2003 Aug; 46(8):1124-30. PubMed ID: 12830382
[TBL] [Abstract][Full Text] [Related]
19. Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats.
Yu YL; Lu SS; Yu S; Liu YC; Wang P; Xie L; Wang GJ; Liu XD
J Ethnopharmacol; 2009 Jul; 124(3):444-9. PubMed ID: 19497359
[TBL] [Abstract][Full Text] [Related]
20. Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.
Prigeon RL; Quddusi S; Paty B; D'Alessio DA
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E701-7. PubMed ID: 12773303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
